Concepedia

Seethalakshmi Hariharan

SH

Statistics

Publications

7

Citations

173

H-Index

7

Active since

2010

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Duke Medical Center

Center for Cancer Research

Seethalakshmi Hariharan is an author at The Ohio State University specializing in gene expression, cell signaling, and medicine.

Top concepts

Publications per year

2010–2024

7

Publications

7

The Rsr1/Bud1 GTPase Interacts with Itself and the Cdc42 GTPase during Bud-Site Selection and Polarity Establishment in Budding Yeast

Pil Jung Kang, Laure Béven, Seethalakshmi Hariharan et al. · Molecular Biology of the Cell · 2010 · 58 citations · Full text

A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

Shengnan Yu, Shiyou Wei, Milan R. Savani et al. · Clinical Cancer Research · 2021 · 29 citations · Full text

Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas

Seethalakshmi Hariharan, Benjamin T. Whitfield, Christopher J. Pirozzi et al. · Nature Communications · 2024 · 22 citations · Full text

The Purα/Purβ Single‐Strand DNA‐Binding Proteins Attenuate Smooth‐Muscle Actin Gene Transactivation in Myofibroblasts

Seethalakshmi Hariharan, Robert J. Kelm, Arthur R. Strauch · Journal of Cellular Physiology · 2014 · 18 citations

, , +23

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma

Peter Y. Yu, Heather L. Gardner, Ryan D. Roberts et al. · PLoS ONE · 2017 · 17 citations · Full text

1–5 of 7